Author

M. R. Capobianchi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:experimental assay· 4 Assay:proteomics· 4 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

G. Ippolito· 3 shared A. Emiliozzi· 2 shared A. Kabanova· 2 shared A. Manenti· 2 shared C. Agrati· 2 shared C. Castilletti· 2 shared C. De Santi· 2 shared C. Sala· 2 shared

Activity by Year

2020-2021 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

G. Ippolito

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

MicrobiologybioRxivPreprintMay 5, 2021

Heparin protects human neural progenitor cells from Zika Virus-induced cell death and preserves their differentiation into mature neural-glia cells

I. Pagani, L. Ottoboni, P. Podini…·E. Vicenzi

DOI 10.1101/2021.05.05.442746

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivNov 3, 2020

Looking for pathways related to COVID-19 phenotypes: Confirmation of pathogenic mechanisms by SARS-CoV-2 - Host interactome.

F. Messina, E. Giombini, C. Montaldo…·G. Ippolito

The paper identifies host-virus interactions and specific SARS-CoV-2 proteins involved in severe COVID-19 phenotypes using network analysis.

DOI 10.1038/s41419-021-03881-8

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivOct 7, 2020

Extremely potent human monoclonal antibodies from convalescent Covid-19 patients

E. Andreano, E. Nicastri, I. Paciello…·R. Rappuoli

The paper isolates extremely potent human monoclonal antibodies from convalescent Covid-19 patients, effective against SARS-CoV-2 at low concentrations.

DOI 10.1016/j.cell.2021.02.035

humanproteomics

𝕏 PostBluesky

BiochemistrybioRxivPreprintJun 5, 2020

Synthetic antibodies neutralize SARS-CoV-2 infection of mammalian cells

S. Miersch, M. Ustav, Z. Li…·S. S. Sidhu

The paper describes synthetic monoclonal antibodies that neutralize SARS-CoV-2 by binding to the spike protein and blocking ACE2 receptor interaction, showing potent antiviral activity.

DOI 10.1101/2020.06.05.137349

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 5, 2020

Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients

E. Andreano, E. Nicastri, I. Paciello…·R. Rappuoli

The paper isolates neutralizing human monoclonal antibodies from Covid-19 convalescent patients for therapeutic and prophylactic interventions.

DOI 10.1101/2020.05.05.078154

humanproteomics

𝕏 PostBluesky